|17.27||-0.07 / -0.40%|
As of 4:00pm ET
|17.28||+0.0051 / +0.03%|
The 2 analysts offering 12-month price forecasts for Osiris Therapeutics Inc have a median target of 22.50, with a high estimate of 26.00 and a low estimate of 19.00. The median estimate represents a +30.28% increase from the last price of 17.27.
The current consensus among 2 polled investment analysts is to Buy stock in Osiris Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.